JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2002) 175, 615-623       DOI: 10.1677/joe.0.1750615
© 2002 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vickers, M.
Right arrow Articles by Breier, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vickers, M.
Right arrow Articles by Breier, B.
Journal of Endocrinology, Vol 175, Issue 3, 615-623
Copyright © 2002 by Society for Endocrinology


Articles

Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment

MH Vickers, BA Ikenasio, and BH Breier


The discovery of a link between an adverse in utero environment and the propensity to develop metabolic and cardiovascular disease in adult life is one of the most important advances in epidemiological research of recent Years. Increasing experimental evidence suggests that alterations in the fetal environment may have long-term consequences for the development of metabolic disorders in adult life. This process has been termed 'fetal programming' and we have shown that undernutrition of the mother during gestation leads to development of the metabolic syndrome X during adult life. Striking metabolic similarities exist between syndrome X and untreated GH deficiency (GHD). In the present study we have investigated the effects of GH treatment on blood pressure and metabolic parameters. Virgin Wistar rats (age 75+/-5 days, n=20 per group) were time-mated and randomly assigned to receive food either ad libitum (AD) or 30% of AD intake (UN) throughout pregnancy. At weaning, male offspring were assigned to one of two diets (control or hypercaloric (30% fat)). Systolic blood pressure was measured at day 100 and following twice daily treatment with recombinant bovine GH for 21 days. GH treatment increased body weights in all treated animals but significantly reduced retroperitoneal and gonadal fat pad weights. Following GH treatment, systolic blood pressure was markedly decreased in all UN offspring. Saline-treated animals showed no change in systolic blood pressure over the treatment period. GH treatment increased heart-to-body weight ratio in all GH-treated animals. Our data demonstrated that GH treatment reduces hypertension and improves cardiovascular function in animals exposed to adverse environmental conditions during fetal or postnatal life.


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Kappeler, C. De Magalhaes Filho, P. Leneuve, J. Xu, N. Brunel, C. Chatziantoniou, Y. Le Bouc, and M. Holzenberger
Early Postnatal Nutrition Determines Somatotropic Function in Mice
Endocrinology, January 1, 2009; 150(1): 314 - 323.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Sagazio, X. Xiao, Z. Wang, M. Martari, and R. Salvatori
A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice
J. Endocrinol., January 1, 2008; 196(1): 79 - 88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Thamotharan, M. Garg, S. Oak, L. M. Rogers, G. Pan, F. Sangiorgi, P. W. N. Lee, and S. U. Devaskar
Transgenerational inheritance of the insulin-resistant phenotype in embryo-transferred intrauterine growth-restricted adult female rat offspring
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1270 - E1279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. H. Vickers, P. L. Hofman, P. D. Gluckman, P. E. Lobie, and W. S. Cutfield
Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1212 - E1219.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. O Krechowec, M. Vickers, A. Gertler, and B. H Breier
Prenatal influences on leptin sensitivity and susceptibility to diet-induced obesity.
J. Endocrinol., May 1, 2006; 189(2): 355 - 363.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. S. Wyrwoll, P. J. Mark, T. A. Mori, I. B. Puddey, and B. J. Waddell
Prevention of Programmed Hyperleptinemia and Hypertension by Postnatal Dietary {omega}-3 Fatty Acids
Endocrinology, January 1, 2006; 147(1): 599 - 606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Thamotharan, B.-C. Shin, D. T. Suddirikku, S. Thamotharan, M. Garg, and S. U. Devaskar
GLUT4 expression and subcellular localization in the intrauterine growth-restricted adult rat female offspring
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E935 - E947.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
I. C. Mcmillen and J. S. Robinson
Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity, and Programming
Physiol Rev, April 1, 2005; 85(2): 571 - 633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. H. Vickers, B. H. Breier, D. McCarthy, and P. D. Gluckman
Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R271 - R273.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.